Joseph D. Dukes
Oxford Science Park, Sanders Road
Oxford, ENG OX44GD, United Kingdom
Oxford, ENG OX44GD, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
MR1-ligand cross-linking identifies vitamin B6 metabolites as TCR-reactive antigens.
Journal: Cell reports methods
Published: July 05, 2024
Conserved allomorphs of MR1 drive the specificity of MR1-restricted TCRs.
Journal: Frontiers in oncology
Published: April 18, 2024
Proceedings of the inaugural Dark Genome Symposium: November 2022.
Journal: Mobile DNA
Published: September 28, 2023
TCRs with Distinct Specificity Profiles Use Different Binding Modes to Engage an Identical Peptide-HLA Complex.
Journal: Journal of immunology (Baltimore, Md. : 1950)
Published: August 01, 2019
Tebentafusp: T Cell Redirection for the Treatment of Metastatic Uveal Melanoma.
Journal: Cancers
Published: June 11, 2019
An approved in vitro approach to preclinical safety and efficacy evaluation of engineered T cell receptor anti-CD3 bispecific (ImmTAC) molecules.
Journal: PloS one
Published: May 17, 2018
Direct molecular mimicry enables off-target cardiovascular toxicity by an enhanced affinity TCR designed for cancer immunotherapy.
Journal: Scientific reports
Published: September 30, 2015
Identification of a Titin-derived HLA-A1-presented peptide as a cross-reactive target for engineered MAGE A3-directed T cells.
Journal: Science translational medicine
Published: August 09, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026